Michael Sinz

4.9k total citations
72 papers, 2.8k citations indexed

About

Michael Sinz is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Sinz has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pharmacology, 30 papers in Oncology and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Sinz's work include Pharmacogenetics and Drug Metabolism (43 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Michael Sinz is often cited by papers focused on Pharmacogenetics and Drug Metabolism (43 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Michael Sinz collaborates with scholars based in United States, Germany and India. Michael Sinz's co-authors include K. R. Krishna Iyer, Thomas F. Woolf, Rory P. Remmel, Sridhar Mani, Roger N. Hayes, Jasminder Sahi, Hongjian Zhang, Sean Kim, Kan He and Paul F. Hollenberg and has published in prestigious journals such as Advanced Drug Delivery Reviews, Oncogene and Clinical Cancer Research.

In The Last Decade

Michael Sinz

71 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Sinz United States	29	1.6k	1.1k	636	442	394	72	2.8k
Kouichi Yoshinari Japan	32	1.7k 1.0×	1.0k 1.0×	1.3k 2.0×	590 1.3×	462 1.2×	153	3.6k
Richard Weaver United Kingdom	36	1.7k 1.0×	1.2k 1.2×	1.2k 1.8×	144 0.3×	375 1.0×	86	3.9k
Norie Murayama Japan	39	3.1k 1.9×	1.6k 1.6×	1.2k 2.0×	679 1.5×	448 1.1×	235	5.0k
Ken Korzekwa United States	27	2.2k 1.3×	1.6k 1.5×	937 1.5×	259 0.6×	353 0.9×	67	3.4k
Lydiane Pichard France	18	1.3k 0.8×	808 0.8×	450 0.7×	252 0.6×	323 0.8×	33	2.2k
Judy L. Raucy United States	37	3.3k 2.0×	1.8k 1.7×	1.6k 2.6×	576 1.3×	495 1.3×	62	5.4k
Masato Chiba Japan	35	1.2k 0.7×	1.7k 1.6×	1.1k 1.7×	163 0.4×	519 1.3×	114	3.7k
Kazuto Yasuda United States	30	2.6k 1.6×	2.7k 2.5×	1.0k 1.6×	569 1.3×	1.4k 3.5×	59	5.4k
Larry C. Wienkers United States	33	2.6k 1.6×	1.2k 1.2×	947 1.5×	337 0.8×	347 0.9×	79	3.9k
P. Kremers Belgium	29	1.7k 1.1×	916 0.9×	906 1.4×	346 0.8×	274 0.7×	77	3.0k

Countries citing papers authored by Michael Sinz

Since Specialization

Citations

This map shows the geographic impact of Michael Sinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sinz more than expected).

Fields of papers citing papers by Michael Sinz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sinz. The network helps show where Michael Sinz may publish in the future.

Co-authorship network of co-authors of Michael Sinz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sinz. A scholar is included among the top collaborators of Michael Sinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sinz. Michael Sinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huo, Runlan, Yueping Zhang, Weiqi Chen, et al.. (2024). A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants. Journal of Pharmacology and Experimental Therapeutics. 390(2). 162–173. 11 indexed citations

Zhang, Yueping, Vinay K. Holenarsipur, Hamza Kandoussi, et al.. (2020). Detection of Weak Organic Anion–Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans. Drug Metabolism and Disposition. 48(10). 841–848. 26 indexed citations

Zhang, Yueping, Cliff Chen, Shen-Jue Chen, et al.. (2020). Absence of OATP1B (Organic Anion–Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression. Journal of Pharmacology and Experimental Therapeutics. 375(1). 139–151. 8 indexed citations

Chen, Weiqi, Yueping Zhang, Michael Sinz, et al.. (2019). Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A. Drug Metabolism and Disposition. 47(11). 1352–1360. 15 indexed citations

Hariparsad, Niresh, Diane Ramsden, Jairam Palamanda, et al.. (2017). Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control. Drug Metabolism and Disposition. 45(10). 1049–1059. 33 indexed citations

Fahmi, Odette A., Mohamad Shebley, Jairam Palamanda, et al.. (2016). Evaluation of CYP2B6 Induction and Prediction of Clinical Drug–Drug Interactions: Considerations from the IQ Consortium Induction Working Group—An Industry Perspective. Drug Metabolism and Disposition. 44(10). 1720–1730. 38 indexed citations

Sinz, Michael. (2013). Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development. Drug Metabolism Reviews. 45(1). 3–14. 54 indexed citations

Einolf, Heidi J., Odette A. Fahmi, Christopher R. Gibson, et al.. (2013). Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction Data. Clinical Pharmacology & Therapeutics. 95(2). 179–188. 73 indexed citations

Raybon, Joseph, Daniel G. Morgan, Mary Zoeckler, et al.. (2010). Pharmacokinetic-Pharmacodynamic Modeling of Rifampicin-Mediated Cyp3a11 Induction in Steroid and Xenobiotic X Receptor Humanized Mice. Journal of Pharmacology and Experimental Therapeutics. 337(1). 75–82. 11 indexed citations

10.

Kim, Sean, Joseph Dinchuk, Mary Zoeckler, et al.. (2009). Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Induction. Drug Metabolism and Disposition. 38(1). 16–24. 39 indexed citations

11.

Gupta, Divya, Madhukumar Venkatesh, Sean Kim, et al.. (2008). Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer. Clinical Cancer Research. 14(17). 5332–5340. 90 indexed citations

12.

Sinz, Michael, et al.. (2008). Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical. The AAPS Journal. 10(2). 391–400. 82 indexed citations

13.

Das, Bhaskar C., Jaime Anguiano, Sean Kim, et al.. (2008). Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR). Bioorganic & Medicinal Chemistry Letters. 18(14). 3974–3977. 26 indexed citations

14.

Zhang, Hongjian, Donghui Cui, Bonnie Wang, et al.. (2007). Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol. Clinical Pharmacokinetics. 46(2). 133–157. 143 indexed citations

15.

Zhu, Zhengrong, Jeremy Stewart, John J. Herbst, et al.. (2007). Use of Cryopreserved Transiently Transfected Cells in High-Throughput Pregnane X Receptor Transactivation Assay. SLAS DISCOVERY. 12(2). 248–254. 19 indexed citations

16.

Sinz, Michael, et al.. (2007). The Utility of Stable Cell Lines to Assess Species Differences in PXR Transactivation. Drug Metabolism Letters. 1(2). 147–152. 8 indexed citations

17.

Sahi, Jasminder, Michael Sinz, Scott Campbell, et al.. (2005). Metabolism and transporter-mediated drug–drug interactions of the endothelin-A receptor antagonist CI-1034. Chemico-Biological Interactions. 159(2). 156–168. 22 indexed citations

18.

Iyer, K. R. Krishna & Michael Sinz. (2001). Discovery Screening Of The In Vitro Cytochrome P450 Inhibitory Potency Of HIV-Protease Inhibitors : Comparison To Saquinavir, Indinavir, Nelfinavir, And PNU 140690. Indian Journal of Pharmaceutical Sciences. 63(5). 401–407.

19.

Iyer, K. R. Krishna & Michael Sinz. (1999). Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations. Chemico-Biological Interactions. 118(2). 151–169. 54 indexed citations

20.

Prasad, J. V. N. Vara, Larry J. Markoski, John M. Domagala, et al.. (1999). Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety. Bioorganic & Medicinal Chemistry Letters. 9(15). 2217–2222. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact